Cargando…
Virulence Factors as Targets for Anticryptococcal Therapy
The global mortality due to cryptococcosis caused by Cryptococcus neoformans or C. gattii is unacceptably high. Currently available therapies are decades old and may be impacted by drug resistance. Therefore, the need for more effective antifungal drugs for cryptococcosis is evident. A number of Cry...
Autores principales: | Azevedo, Renata V. D. M., Rizzo, Juliana, Rodrigues, Marcio L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715936/ https://www.ncbi.nlm.nih.gov/pubmed/29376946 http://dx.doi.org/10.3390/jof2040029 |
Ejemplares similares
-
Isolated cutaneous acanthamoebiasis under prophylactic anticryptococcal treatment in an immunocompromised patient
por: Stetkevich, Samuel A., et al.
Publicado: (2022) -
Ring-Modified Histidine-Containing Cationic Short Peptides Exhibit Anticryptococcal Activity by Cellular Disruption
por: Sharma, Komal, et al.
Publicado: (2022) -
Behind the Curtain: In Silico and In Vitro Experiments Brought to Light New Insights into the Anticryptococcal Action of Synthetic Peptides
por: Aguiar, Tawanny K. B., et al.
Publicado: (2023) -
Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients
por: Kyei, Stephen K., et al.
Publicado: (2016) -
Where Do They Come from and Where Do They Go: Candidates for Regulating Extracellular Vesicle Formation in Fungi
por: Oliveira, Débora L., et al.
Publicado: (2013)